GS-4571

Phase 1Small molecule

Gilead

GS-4571 is one of 6 small molecule programs targeting Weight Management. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Weight ManagementRecruiting

Weight ManagementPhase 1

Recruiting

Competition

Competitive Landscape

7 competitors in Weight Management

#DrugCompanyPhaseTrials

VK2735

VViking Therapeutics, Inc.

Phase 3

3 2

Prilosec

DDexcel Pharma Technologies Ltd.

Phase 1

1 3

HRS9531

FFujian Shengdi Pharmaceutical Co., Ltd.

Phase 1

1 4

Meridia

AAbbott

Preclinical

1 5

GS-4571

Gilead

Phase 1

1 6

Febuxostat Tab

XXuhui Central Hospital, Shanghai

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1Recruiting

Weight Management

NCT06562907

Clinical

Trials by Indication[1]

Weight Management1 trial

A Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Oral Doses of GS-4571 in Healthy Participants, Multiple Ascending Oral Doses of GS-4571 in Nondiabetic Obese Participants and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM), and to Evaluate the Effect of Food and an Acid-Reducing Agent on Pharmacokinetics of GS-4571

Recruiting· Gilead logo

Gilead·Phase 1·NCT06562907·134 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for GS-4571. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — GS-4571 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for GS-4571. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Gilead company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: Gilead

GS-4571

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Weight Management1 trial

References

Drug Info

Quick Facts

Related News